HLA-A*0201 & B2M & HPV16-E7

お問い合わせ

HLA-A*0201 & B2M & HPV16-E7バックグランド

Human papillomavirus (HPV) is A kind of papillomavirus belonging to the milk polypoid virus family. It is a spherical DNA virus, which can cause the proliferation of squamous epithelium of human skin mucosa. HPV(human papillomavirus) for common warts, genital warts (condyloma acuminatum), and other symptoms. There are many types of human papillomavirus (HPV), with HPV 16 and 18 being high-risk types known to significantly increase the risk of cervical, vaginal and vulvar cancers in women and men. The human HLA-A*0201 HPV (YMLDLQPET) tetramer protein is a complex of HLA-A*0201 of the MHC Class I, B2M, and YMLDLQPET peptide of the HPV.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
BosakitugBSI-045B; TQC-2731; TQC2731Phase 3 ClinicalBiosion IncNasal Polyps; Sinusitis; Asthma; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic
詳細
EcleralimabCSJ-117; NOV-14Phase 2 ClinicalNovartis Pharma AgAsthma; Pulmonary Disease, Chronic Obstructive
詳細
WIN-1001XWIN-1001XPhase 2 ClinicalWhanin Pharmaceutical Co LtdNerve Degeneration; Parkinson Disease
詳細
PF-07275315PF-07275315Phase 2 ClinicalPfizer IncDermatitis, Atopic
詳細
LunsekimigSAR-443765Phase 2 ClinicalSanofiNasal Polyps; Asthma; Sinusitis; Inflammation
詳細
AZD-8630AZD-8630; AMG-104Phase 2 ClinicalAstrazeneca Plc, Amgen IncAsthma
詳細
SHR-1905SHR-1905; AIO-001Phase 2 ClinicalNasal Polyps; Respiratory Tract Diseases; Sinusitis; Asthma; Pulmonary Disease, Chronic Obstructive
詳細
CM-326(Connaught Biomedical Technology)CM-326Phase 2 ClinicalKeymed Biosciences Co LtdNose Diseases; Nasal Polyps; Asthma; Sinusitis; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic
詳細
PF-06342674RN-168; PF-6342674; PF-06342674; ZB-168Phase 1 ClinicalPfizer IncDiabetes Mellitus, Type 1; Multiple Sclerosis
詳細
HBM-9378SKB378; HBM-9378Phase 1 ClinicalHarbour Biomed, Sichuan Kelun-Biotech Biopharmaceutical Co LtdAsthma
詳細
HB-0056HB-0056; HB0056Phase 1 ClinicalShanghai Huaota Biopharmaceutical Co LtdAsthma
詳細
IBI-3002IBI3002; IBI-3002Phase 1 ClinicalInnovent Biologics(Suzhou) Co LtdAsthma
詳細
GB-0895GB-0895Phase 1 ClinicalImmune System Diseases; Asthma
詳細
STSA-1201STSA-1201; STSA1201Phase 1 ClinicalAsthma
詳細
LQ043HLQ043HPhase 1 ClinicalShanghai Novamab Biopharmaceuticals Co LtdAsthma
詳細
GR2002GR2002Phase 1 ClinicalGenrix (Shanghai) Biopharmaceutical Co LtdNasal Polyps; Asthma; Sinusitis; Dermatitis, Atopic
詳細
QX-008NQX008N; QX-008NPhase 1 ClinicalQyuns Therapeutics Co LtdAsthma; Pulmonary Disease, Chronic Obstructive
詳細
BD-9BD-9Biolojic Design Inc
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
TezepelumabAMG-157; MEDI-9929ApprovedAmgen IncTezspireUnited StatesAsthmaAstrazeneca Ab2021-12-17Eosinophilic Esophagitis; Hypersensitivity; Dermatitis, Atopic; Hypersensitivity, Immediate; Bronchial Diseases; Pulmonary Disease, Chronic Obstructive; Respiratory Hypersensitivity; Sinusitis; Asthma; Granulomatosis with Polyangiitis; Lung Diseases; Immune System Diseases; Chronic Urticaria; Respiratory Tract Diseases; Nasal Polyps; Anaphylaxis; Carcinoma; Lung Diseases, Obstructive
詳細
  • お問い合わせ
  • 市販薬剤に関する情報
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8